Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 18 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 10113170

    Preventing and treating inflammatory skin diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  2. US 10113145

    Paenibacillus sp. strain, cultivation method and use of the same

    BRIGHT DAIRY & FOOD CO., LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  3. US 10111923

    Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  4. US 10105408

    Traditional Chinese medicine composition and preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  5. US 10105379

    Pharmaceutical compositions comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  6. US 10098925

    Protein SLURP-1 for use in the treatment of ocular diseases

    Brightpulse Holding Ltd. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  7. US 10098889

    Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  8. US 10098372

    Whitening composition and the use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  9. US 10093698

    Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same

    CAREGEN CO., LTD. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  10. US 10087232

    Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

    Protalix Ltd. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  11. US 10080775

    Peptide having skin whitening activity, and use thereof

    CAREGEN CO., LTD. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  12. US 10080720

    Pharmaceutical composition containing docetaxel

    GAINIA (SHANGHAI) PATENT TECHNOLOGY LTD. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  13. US 10080379

    Zinc and copper fortifying composition, a hydrating supplement, and process for preparing the same

    Tata Global Beverages Ltd. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  14. US 10076527

    Standardized extract and its use in the manufacture of a medicament

    Botanic Century (Beijing) Co. Ltd. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  15. US 10072122

    Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof

    BRIGHTGENE BIO-MEDICAL TECHNOLOGY (SUZHOU) CO., LTD. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  16. US 10071358

    Antibiotic preparation method and platform system based on same

    PROTEIN DESIGN LAB, LTD. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  17. US 10065928

    Quinolinone compound and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  18. US 10065934

    Substituted urea derivatives and pharmaceutical uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  19. US 10064889

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  20. US 10058593

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  21. US 10059689

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  22. US 10052363

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted
  23. US 10047125

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  24. US 10046010

    Methods of generating mesenchymal stem cells which secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted